Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valle

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Investigation|September 24, 2025
PD-L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single-center retrospective studyGabriele Gaggero, Alessandro Pesaresi, Debora Giunti, et al.
European Journal of Clinical Investigation|December 7, 2025
Fibroblast-driven MMP-9/TIMP-1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung diseaseMaria Bertolotto, Daniela de Totero, Paolo Giannoni, et al.
Cancers|September 28, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Infectious Agents and Cancer|January 12, 2024
A systematic review of endometrial cancer clinical research in AfricaChidinma P Anakwenze, Agnes Ewongwo, Louisa Onyewadume, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Frontiers in Oncology|May 7, 2020
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate CancerRebecca Levin-Epstein, George Qiao-Guan, Jesus E Juarez, et al.
Cancers|September 28, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2023
Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging TrialsClayton P Smith, Michael Xiang, Wesley R Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Investigation|September 24, 2025
PD-L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single-center retrospective studyGabriele Gaggero, Alessandro Pesaresi, Debora Giunti, et al.
European Journal of Clinical Investigation|December 7, 2025
Fibroblast-driven MMP-9/TIMP-1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung diseaseMaria Bertolotto, Daniela de Totero, Paolo Giannoni, et al.
Cancers|September 28, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Infectious Agents and Cancer|January 12, 2024
A systematic review of endometrial cancer clinical research in AfricaChidinma P Anakwenze, Agnes Ewongwo, Louisa Onyewadume, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Frontiers in Oncology|May 7, 2020
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate CancerRebecca Levin-Epstein, George Qiao-Guan, Jesus E Juarez, et al.
Cancers|September 28, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2023
Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging TrialsClayton P Smith, Michael Xiang, Wesley R Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Pageof 5